29 February 2024
CHINA PACIFIC INSURANCE (GROUP) CO., LTD.
(A joint stock company incorporated in the People's Republic of China with limited liability)
Election of Directors and Shareholder Representative Supervisors, Appointment of Chairman and Vice Chairman of The Board of Directors, President and the Members of the Special Committees of the 10th Session of the Board of Directors
Reference is made to the announcement on the poll results of the extraordinary general meeting (the "EGM") of China Pacific Insurance (Group) Co., Ltd. (the "Company") dated 29 February 2024.
ELECTION OF DIRECTORS OF THE 10TH SESSION OF THE BOARD OF DIRECTORS
Through the votes of the shareholders of the Company at the EGM, the election and re-election of all the director candidates of the 10th session of the board of directors of the Company (the "Board of Directors") were duly approved by the shareholders of the Company. According to the relevant regulatory requirements, the appointment of each of Mr. FU Fan, Mr. HUANG Dinan, Mr. WANG Tayu, Mr. CHEN Ran, Mr. ZHOU Donghui, Ms. LU Qiaoling, Mr. John Robert DACEY, Ms. LIU Xiaodan, Ms. LAM Tyng Yih, Elizabeth, Ms. LO Yuen Man, Elaine, Mr. CHIN Hung I David and Mr. JIANG Xuping as a director of the 10th session of the Board of Directors took effect on the date of the EGM. The appointment qualification of Mr. ZHAO Yonggang is still subject to the approval by the National Administration of Financial Regulation (the "NAFR").
The biographical details of the above directors were set out in the notice of the Company dated 5 February 2024.
The term of office of Mr. WU Junhao, being a director of the 9th session of the Board of Directors, has expired. The Company would like to thank Mr. WU Junhao for his contributions to the Company made during his period of service.
ELECTION OF SHAREHOLDER REPRESENTATIVE SUPERVISORS OF THE 10TH SESSION OF THE BOARD OF SUPERVISORS
Through the votes of shareholders of the Company at the EGM, the election and re-election of all the shareholder representative supervisor candidates of the 10th session of the board of supervisors of the Company (the "Board of Supervisors") were duly approved by the shareholders of the Company. According to the relevant regulatory requirements, the appointment of Mr. ZHU Yonghong as a shareholder representative supervisor of the 10th session of the Board of Supervisors took effect on the date of the EGM. The appointment of Mr. YUE Lin is still subject to the approval by the NAFR.
The biographical details of the above supervisors were set out in the notice of the Company dated 5 February 2024.
The term of office of Mr. LU Ning, being a shareholder representative supervisor of the 9th session of the Board of Supervisors, has expired. The Company would like to thank Mr. LU Ning for his contributions to the Company made during his period of service.
Until the completion of the election of the new session of the Board of Supervisors, the ninth session of the Board of Supervisors is still required to perform its duties in accordance with relevant laws and regulations as well as the provisions of the Articles of Association.
APPOINTMENT OF CHAIRMAN, VICE CHAIRMAN OF THE BOARD OF DIRECTORS AND PRESIDENT
The Company is pleased to announce that the first meeting of the 10th session of the Board of Directors was held on 29 February 2024. At the meeting, Mr. FU Fan was elected as the Chairman of the Board of Directors, Mr. HUANG Dinan was elected as the Vice Chairman of the Board of Directors, and Mr. ZHAO Yonggang was appointed as President.
APPOINTMENT OF THE MEMBERS OF THE SPECIAL COMMITTEES OF THE 10TH SESSION OF THE BOARD OF DIRECTORS
The Board of Directors herby announces that the Audit Committee has been renamed to Audit and Related Party Transaction Control Committee and Risk Management and Related Party Transaction Control Committee has been renamed to Risk Management Committee.
The 10th session of the Board of Directors has five committees, namely the Strategic and Investment Decision-Making & ESG Committee, the Audit and Related Party Transaction Control Committee, the Nomination and Remuneration Committee, the Risk Management Committee and the Technological Innovation and Consumer Rights Protection Committee. The composition of each committee is as follows:
Strategic and Investment Decision-Making & ESG Committee
Chairman: FU Fan (Executive Director)
Other members: CHIN Hung I David (Independent Non-executive Director)
HUANG Dinan (Non-executive Director)
LU Qiaoling (Non-executive Director)
John Robert DACEY (Non-executive Director)
Audit and Related Party Transaction Control Committee
Chairman: LAM Tyng Yih, Elizabeth (Independent Non-executive Director)
Other members: LO Yuen Man, Elaine (Independent Non-executive Director)
ZHOU Donghui (Non-executive Director)
JIANG Xuping (Independent Non-executive Director)
Nomination and Remuneration Committee
Chairman: LIU Xiaodan (Independent Non-executive Director)
Other members: WANG Tayu (Non-executive Director)
CHIN Hung I David (Independent Non-executive Director)
JIANG Xuping (Independent Non-executive Director)
Risk Management Committee
Chairman: ZHAO Yonggang (Executive Director)
Other members: WANG Tayu (Non-executive Director)
LAM Tyng Yih, Elizabeth (Independent Non-executive Director)
LO Yuen Man, Elaine (Independent Non-executive Director)
Technological Innovation and Consumer Rights Protection Committee
Chairman: JIANG Xuping (Independent Non-executive Director)
Other members: CHEN Ran (Non-executive Director)
ZHOU Donghui (Non-executive Director)
ZHAO Yonggang (Executive Director)
By Order of the Board of Directors
China Pacific Insurance (Group) Co., Ltd.
FU Fan
Chairman
About CPIC
CPIC is a joint stock company established under the laws of the People's Republic of China with limited liability.
CPIC's registered office is located at 1 South Zhongshan Road, Huangpu District, Shanghai, the People's Republic of China.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.